Molecular Partners AG
MOLN
$4.34
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | 787.30K | 2.50M | 5.63M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | 787.30K | 2.50M | 5.63M |
| Cost of Revenue | 46.89M | 47.41M | 49.56M | 51.05M | 53.92M |
| Gross Profit | -46.89M | -47.41M | -48.77M | -48.55M | -48.29M |
| SG&A Expenses | 19.65M | 20.13M | 20.72M | 20.79M | 21.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.54M | 67.54M | 70.28M | 71.84M | 75.15M |
| Operating Income | -66.54M | -67.54M | -69.49M | -69.34M | -69.52M |
| Income Before Tax | -74.01M | -70.97M | -75.14M | -67.09M | -61.38M |
| Income Tax Expenses | 2.80K | 100.00 | 100.00 | 100.00 | 2.30K |
| Earnings from Continuing Operations | -74.01 | -70.97 | -75.14 | -67.09 | -61.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.01M | -70.97M | -75.14M | -67.09M | -61.39M |
| EBIT | -66.54M | -67.54M | -69.49M | -69.34M | -69.52M |
| EBITDA | -64.32M | -65.31M | -67.24M | -67.09M | -67.19M |
| EPS Basic | -1.99 | -1.91 | -2.09 | -1.93 | -1.81 |
| Normalized Basic EPS | -1.19 | -1.14 | -1.25 | -1.20 | -1.13 |
| EPS Diluted | -1.99 | -1.91 | -2.09 | -1.93 | -1.82 |
| Normalized Diluted EPS | -1.19 | -1.14 | -1.25 | -1.20 | -1.13 |
| Average Basic Shares Outstanding | 149.08M | 148.55M | 144.34M | 140.13M | 136.13M |
| Average Diluted Shares Outstanding | 149.08M | 148.55M | 144.34M | 140.13M | 136.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |